In yesterday’s Wall Street session, Insmed Inc (NASDAQ:INSM) shares traded at $61.63, down -0.03% from the previous session.
INSM stock price is now 85.55% away from the 50-day moving average and 117.68% away from the 200-day moving average. The market capitalization of the company currently stands at $9.94B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $48, Truist recently initiated with Buy rating for Insmed Inc (NASDAQ: INSM). On February 15, 2024, Wolfe Research recently initiated its ‘Outperform’ rating on the stock quoting a target price of $42, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, Flammer Martina M.D., Chief Medical Officer sold 21,195 shares of the company’s stock on Jun 10 ’24. The stock was sold for $1,271,700 at an average price of $60.00. Upon completion of the transaction, the Chief Medical Officer now directly owns 106,134 shares in the company, valued at $6.54 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 03 ’24, Chief People Strategy Officer Schaeffer Orlov S Nicole sold 55,000 shares of the business’s stock. A total of $3,043,150 was realized by selling the stock at an average price of $55.33. This leaves the insider owning 108,760 shares of the company worth $6.7 million. A total of 2.99% of the company’s stock is owned by insiders.
During the past 12 months, Insmed Inc has had a low of $18.77 and a high of $63.23. The fifty day moving average price for INSM is $33.8946 and a two-hundred day moving average price translates $28.51245 for the stock.
The latest earnings results from Insmed Inc (NASDAQ: INSM) was released for 2024-03-31. The net profit margin was -236.74% and return on equity was -1453.41% for INSM. The company reported revenue of $75.5 million for the quarter, compared to $65.21 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.77 percent.
